Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
The evidence base for TB-500 is thinner than BPC-157s, with essentially no human randomised controlled trial data (source)
It appears to upregulate vascular endothelial growth factor (VEGF), a key signalling protein that triggers the growth of new capillaries into damaged tissue
Medical directors need to review protocols, especially if a patient doesn't respond after 4-6 weeks, side effects appear, or new regulations come up
2022 Dec 14;13:1026182
Temperature changes, chills, hair shedding, sulfur-tasting burps, and low mood appear in user reports but were measured thinly or not at all in trials
US$ 27.38
US$ 26.18
US$ 22.26
US$ 25.34
US$ 28.87
US$ 22.72
